Beyond the numbers in treating hypertensive end-organ damage: role of formyl peptide receptor agonist Cmpd17b
Cardiovascular Research · 2024
DOI: 10.1093/cvr/cvae134 ↗Kurz gefasst
Editorial in der Zeitschrift Cardiovascular Research, 2024. Verfasst von Claude F Albritton und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, 560 Preston Cancer Research Building, 2220 Pierce Av…. Hauptthemen laut MEDLINE: Hypertension, Receptors, Formyl Peptide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The UNCF/Bristol-Myers Squibb E.E. Just Faculty Fund, Chan Zuckerberg Initiative's Donor-Advised Fund, NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, 560 Preston Cancer Research Building, 2220 Pierce Ave, Nashville, TN 37232, USA.
- Department of Biomedical Sciences, School of Graduate Studies, Meharry Medical College, Nashville, TN 37208-3501, USA.
- Department of Molecular Physiology & Biophysics, Vanderbilt University, 750 Robinson Research Building, 2200 Pierce Ave, Nashville, TN 37232-0615, USA.
- Vanderbilt Center for Immunobiology, 1211 Medical Center Drive, Nashville, TN 37232-0615, USA.
- Vanderbilt Institute for Infection, Immunology and Inflammation, 1161 21st Ave South Medical Center North A-5121, Nashville, TN 37232-0615, USA.
- Vanderbilt Institute for Global Health, 2525 West End Avenue, Suite 750, Nashville, TN 37203, USA.
ORCID-Profile: Antentor Hinton, Annet Kirabo
Förderung
- The UNCF/Bristol-Myers Squibb E.E. Just Faculty Fund
- Chan Zuckerberg Initiative's Donor-Advised Fund
- NIH HHS
- NIAID NIH HHS
- NHLBI NIH HHS
- Silicon Valley Community Foundation
- Science Diversity Leadership
- Burroughs Wellcome Fund
Zitieren
APA
Albritton, C. F., Hinton, A., & Kirabo, A. (2024). Beyond the numbers in treating hypertensive end-organ damage: role of formyl peptide receptor agonist Cmpd17b. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae134
Vancouver
Albritton CF, Hinton A, Kirabo A. Beyond the numbers in treating hypertensive end-organ damage: role of formyl peptide receptor agonist Cmpd17b. Cardiovascular Research. 2024. doi:10.1093/cvr/cvae134
BibTeX
@article{Albritton2024,
author = {Albritton, Claude F and Hinton, Antentor and Kirabo, Annet},
title = {Beyond the numbers in treating hypertensive end-organ damage: role of formyl peptide receptor agonist Cmpd17b},
journal = {Cardiovascular Research},
year = {2024},
doi = {10.1093/cvr/cvae134}
}
EUVIMED